You just clicked a link to go to another website. If you continue, you will leave this site and go to a site run by someone else.
Medtronic does not review or control the content on the other website, and we are not responsible for any business dealings or transactions you have there. Your use of the other site is subject to the terms of use and privacy statement on that site.
It is possible that some of the products on the other site are not approved in the Indian Subcontinent.
Any and all information provided is intended for general overview. Viewers taking any decision based on the information provided herein are requested to seek professional advice.
Your browser is out of date
With an updated browser, you will have a better Medtronic website experience. Update my browser now.
The content of this website is exclusively reserved for Healthcare Professionals in countries with applicable health authority product registrations.
Click “OK” to confirm you are a Healthcare Professional.
COMMUNICATION IS CRITICAL
Evidence suggests that breakdowns in the bowel-brain communication pathway are the root cause of chronic fecal incontinence (FI)1,2 While other therapies focus on the bowel muscles, Medtronic therapies target the nerves, which is thought to help restore normal bowel function.2
THE RELIEF YOU’VE BEEN WAITING FOR
When more conservative treatments fail, Medtronic bowel control therapy delivered by the InterStim™ system can help. This therapy is so simple and discreet you might forget you have it. And it delivers the kind of relief that lets you enjoy the activities you love without a second thought.
Implanting an InterStim™ system has risks similar to any surgical procedure, including swelling, bruising, bleeding, and infection. Talk with your doctor about ways to minimize these risks.
Medtronic bowel control therapy delivered by the InterStim™ system provides life-changing relief.
The most frequently occurring device/therapy-related adverse events were implant site pain, paresthesia, change in sensation of stimulation, implant site infection, urinary incontinence, neurostimulator battery depletion, diarrhea, pain in extremity, undesirable change in stimulation, and buttock pain.
Hear from people who have successfully reduced their symptoms with help from Medtronic bowel control therapy.
READ PATIENT STORIESBowel control problems affect millions of people. But relief is closer than you think.
SEE THE STEPSTalking about bowel control problems can be difficult. But this doctor discussion guide can help you get through it more easily.
GET THE GUIDERead a quick overview to understand your options and see if Medtronic bowel control therapy might be right for you.
READ THE BROCHUREThe care pathway helps you understand all of the treatment options available for bowel control problems.
GET THE PATHWAYRestored bowel function is defined as 50% or more reduction in chronic fecal incontinence episodes.
Success defined as ≥ 50% reduction of episodes/week. This patient group had data at both baseline and the 5 year visit. Another analysis reported 69% of people achieved success with Medtronic Bowel Control Therapy. For this patient group, missing data at 5 years because of a device-related reason was counted as failure or if it was missing for non-device related reasons, the most recent data was carried forward.
Tjandra JJ, Chan MKY, Yeh CH, Murray-Green C. Sacral nerve stimulation is more effective than optimal medical therapy for severe fecal incontinence: a randomized, controlled study. Dis Colon Rectum. 2008;51(5):494–502.
Gourcerol G, Vitton V, Leroi AM, et al. How sacral nerve stimulation works in patients with faecal incontinence. Colorectal Dis. 2011;13(8):e203–211.
Hull T, Giese C, Wexner SD, Mellgren A, Devroede G, et al. Long-term durability of sacral nerve stimulation therapy for chronic fecal incontinence. Dis Colon Rectum. 2013;56:234–245.
Information on this site should not be used as a substitute for talking with your doctor. Always talk with your doctor about diagnosis and treatment information.